DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings

Top Holdings381 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.1M$613.9M5.1%$64.83+205.01%
24 qtrssince 2019-Q1
Increased
62

CRINETICS PHARMACEUTICALS IN

6.1M$314M2.6%$26.16+93.68%
19 qtrssince 2020-Q2
Increased
55
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

6.8M$203.3M1.7%$18.81+57.46%
24 qtrssince 2019-Q1
Increased
49

XENON PHARMACEUTICALS INC

4.5M$177.2M1.5%$27.43+40.48%
20 qtrssince 2020-Q1
Decreased
0

ASTERA LABS INC

1.3M$175.4M1.4%$131.97+0.36%
2 qtrssince 2024-Q3
Increased
77

MODINE MANUFACTURING CO

1.4M$166.9M1.4%$67.80+73.51%
9 qtrssince 2022-Q4
Increased
49
CYBRCYBRDelisted

CYBERARK SOFTWARE LTD

478,096$159.3M1.3%$218.08+46.55%
13 qtrssince 2021-Q4
Increased
61

FTAI AVIATION LTD

1.1M$157M1.3%$27.55+414.77%
8 qtrssince 2023-Q1
Decreased
0

NATERA INC

923,045$146.1M1.2%$73.29+116.32%
10 qtrssince 2022-Q3
Increased
50

Core Scientific Inc

10.3M$144.2M1.2%$13.07+6.20%
2 qtrssince 2024-Q3
Increased
77

SEMTECH CORP

2M$125.7M1.0%$35.40+74.28%
3 qtrssince 2024-Q2
Decreased
0

GLAUKOS CORP

820,123$123M1.0%$85.88+74.08%
7 qtrssince 2023-Q2
Decreased
0

FRESHPET INC

810,646$120.1M1.0%$95.19-23.68%
6 qtrssince 2023-Q3
Increased
45

SPROUTS FMRS MKT INC

942,785$119.8M1.0%$65.31+94.92%
5 qtrssince 2023-Q4
Increased
45

AXON ENTERPRISE INC

201,035$119.5M1.0%$198.84+198.89%
21 qtrssince 2019-Q4
Decreased
0

APOGEE THERAPEUTICS INC

2.6M$118M1.0%$40.90+9.13%
6 qtrssince 2023-Q3
Increased
44

II-VI INC

1.2M$116.5M1.0%$71.58+32.50%
4 qtrssince 2024-Q1
Decreased
0

CAMECO CORP

2.2M$115.4M1.0%$41.52+23.38%
14 qtrssince 2021-Q3
Increased
68

FLOWSERVE CORP

1.9M$108.7M0.9%$55.10+2.76%
2 qtrssince 2024-Q3
Increased
68

CURTISS-WRIGHT CORP

291,582$103.5M0.9%$238.29+49.83%
12 qtrssince 2022-Q1
Increased
43
$12.1B
AUM
381
Positions
Q4 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
-3%Q3'23$7.7B+8%Q4'23$8.3B+21%Q1'24$10B+3%Q2'24$10.3B+13%Q3'24$11.6B+4%Q4'24$12.1B
Activity profile
$ moved · Q4'24
New22%Increased31%Decreased27%Exited20%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q12%1-4Q21%1-2Y14%2Y+52%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $12.1B across 381 positions as of Q4 2024. Top holdings: TSM (5.1%), CRNX (2.6%), IBN (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2024 Summary

Active quarter - 91 new positions, 85 exits, 122 increased. Top move: ALAB (INCREASED, conviction 77). Portfolio: $12.1B across 381 positions.

Top holdings by portfolio weight

Total AUM$12B
TSM5.07%
CRNX2.59%
IBN1.68%
XENE1.46%
ALAB1.45%
MOD1.38%
CYBR1.31%
FTAI1.30%
NTRA1.21%
CORZ1.19%
Other1.04%

Portfolio allocation by GICS sector

Sectors11
Technology23.12%
Healthcare22.04%
Industrials17.65%
Consumer Cyclical12.06%
Financial Services10.75%
Energy4.25%
Consumer Defensive4.11%
Basic Materials2.39%
Communication Services1.90%
Unknown0.97%
Other0.76%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Healthcare, Industrials
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used